TherapeuticsMD
TXMD
81 hedge funds and large institutions have $422M invested in TherapeuticsMD in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 13 closing their positions.
87% more call options, than puts
Call options by funds: $144K | Put options by funds: $77K
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more ownership
Funds ownership: 1.22% → 1.22% (+0%)
5% less capital invested
Capital invested by funds: $442M → $422M (-$20M)
1% less funds holding
Funds holding: 82 → 81 (-1)
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.98M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$3.01M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.3M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.27M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$6.45M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.02M |
| 3 |
Goldman Sachs
New York
|
-$1.63M |
| 4 |
Bank of New York Mellon
New York
|
-$1.46M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1M |
TXMD Hedge Fund Activity: Q4 2014 in Review
81 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2014, worth a combined $422M — down 4.5% from $442M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TXMD positions and 13 closed out — a net gain of 1 holder — while 23 added to existing stakes and 31 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.98M. The largest seller was Massachusetts Financial Services, cutting an estimated $6.45M.
- 81 institutional investors held TherapeuticsMD (TXMD) as of Q4 2014, down from 82 in Q3 2014.
- Funds reported $422M of TherapeuticsMD stock for Q4 2014, down 4.5% quarter-over-quarter.
- 14 funds opened new TherapeuticsMD positions in Q4 2014 and 13 closed out, a net change of +1 holder.
- The largest TherapeuticsMD buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $4.98M added.
- The largest TherapeuticsMD seller in Q4 2014 was Massachusetts Financial Services, an estimated $6.45M sold.
Based on aggregated 13F filings for Q4 2014.